1-17 of 17
Hans Krause
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3181: Expression changes of the chromatin modifier PBRM1 in human renal cell carcinomas in relation to histopathological features

Hans Krause, Anica Högner, Burkhard Jandrig, Ergin Kilic, Carsten Kempkensteffen
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3181.
https://doi.org/10.1158/1538-7445.AM2016-3181
Published: 15 July 2016
View articletitled, Abstract 3181: Expression changes of the chromatin modifier PBRM1 in human renal cell carcinomas in relation to histopathological features
Journal Articles

Abstract 3992: Value of miRNA profiling in urine to predict significant prostate cancer

Hans Krause, Hannes Cash, Liam Stelzer, Kurt Miller, Carsten Kempkensteffen
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3992.
https://doi.org/10.1158/1538-7445.AM2015-3992
Published: 01 August 2015
View articletitled, Abstract 3992: Value of miRNA profiling in urine to predict significant prostate cancer
Journal Articles

Abstract LB-88: The role of PBRM1 as tumor suppressor gene in renal cell carcinomas

Burkhard Jandrig, Odiljon Ikromov, Anica Hoegner, Johann J. Wendler, Martin Schostak, Hans Krause
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-88.
https://doi.org/10.1158/1538-7445.AM2014-LB-88
Published: 01 October 2014
View articletitled, Abstract LB-88: The role of PBRM1 as tumor suppressor gene in renal cell carcinomas
Journal Articles

Abstract 1367: An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis

Hans Krause, Imad Al-Kamal, Odiljon Ikromov, Kurt Miller, Carsten Kempkensteffen
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1367.
https://doi.org/10.1158/1538-7445.AM2014-1367
Published: 01 October 2014
View articletitled, Abstract 1367: An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis
Journal Articles

Abstract 2972: Pharmacological reactivation of epigenetically regulated genes in prostate cancer.

Hans Krause, Odiljon Ikromov, Imad Al Kamal, Ahmed Magheli, Carsten Kempkensteffen, Kurt Miller
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2972.
https://doi.org/10.1158/1538-7445.AM2013-2972
Published: 15 April 2013
View articletitled, Abstract 2972: Pharmacological reactivation of epigenetically regulated genes in prostate cancer.
Journal Articles

Abstract 2170: The SWI/SNF nucleosome-remodeling gene PBRM1 - Another tumor suppressor gene in renal cell carcinomas

Hans Krause, Odiljon Ikromov, Eymad All Kamal, Kurt Miller, Martin Schostak, Burkhard Jandrig
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2170.
https://doi.org/10.1158/1538-7445.AM2012-2170
Published: 15 April 2012
View articletitled, Abstract 2170: The SWI/SNF nucleosome-remodeling gene PBRM1 - Another tumor suppressor gene in renal cell carcinomas
Journal Articles

Abstract 3025: Efficiency of bisulfite modification and DNA recovery in clinical samples with minute amounts of circulating DNA

Hans Krause, Olga Bryzgunova, Pavel P. Laktionov, Tatyana Skvortsova, Anna Bondar, Evgeniy Morozkin, Alena Lebedeva, Valentin Vlassov, Kurt Miller
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3025.
https://doi.org/10.1158/1538-7445.AM2011-3025
Published: 15 April 2011
View articletitled, Abstract 3025: Efficiency of bisulfite modification and DNA recovery in clinical samples with minute amounts of circulating DNA
Journal Articles

Abstract 4675: Lack of evidence for XMRV infection in German prostate cancer patients

Hans Krause, Oliver Hohn, Kurt Miller, Reinhard Kurth, Norbert Bannert
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4675.
https://doi.org/10.1158/1538-7445.AM10-4675
Published: 15 April 2010
View articletitled, Abstract 4675: Lack of evidence for XMRV infection in German prostate cancer patients
Journal Articles

Abstract #1610: The role of MCL1 splice variants in renal cell carcinomas - Correlation with histopathological parameters and prognosis

Hans Krause, Carsten Kempkensteffen, Mark Schrader, Kurt Miller, Steffen Weikert
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1610.
Published: 01 May 2009
View articletitled, Abstract #1610: The role of MCL1 splice variants in renal cell carcinomas - Correlation with histopathological parameters and prognosis
Journal Articles

Serum proteomic profiling by SELDI TOF-MS discriminates prostate cancer patients from patients with benign hyperplasia (BPH) and healthy controls

Hans Krause, Sonja Vorderwuelbecke, Christian Wolf, Kurt Miller, Mark Schrader
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5154.
Published: 01 May 2008
View articletitled, Serum proteomic profiling by SELDI TOF-MS discriminates prostate cancer patients from patients with benign hyperplasia (BPH) and healthy controls
Journal Articles

Inhibitors of apoptosis cIAP1 and cIAP2 expression in renal cell carcinomas and their prognostic relevance

Hans Krause, Carsten Kempkensteffen, Kurt Miller, Steffen Weikert
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2699.
Published: 01 May 2007
View articletitled, Inhibitors of apoptosis cIAP1 and cIAP2 expression in renal cell carcinomas and their prognostic relevance
Journal Articles

RT-PCR for PSA mRNA improves the detection of metastases in pelvic lymph nodes of prostate cancer patients.

Hans Krause, Martin Schostak, Mark Schrader, Kurt Miller
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1242–1243.
Published: 15 April 2006
View articletitled, RT-PCR for PSA mRNA improves the detection of metastases in pelvic lymph nodes of prostate cancer patients.
Journal Articles

Quantitative real-time RT-PCR for AMACR distinguishes prostate cancer with high specificity from benign lesions

Martin Schostak, Hans Krause, Jens Köllermann, Heinz Bodenmüller, Kurt Miller
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 744.
Published: 01 May 2005
View articletitled, Quantitative real-time RT-PCR for AMACR distinguishes prostate cancer with high specificity from benign lesions
Journal Articles

The enhancer of zeste homolog 2 (EZH2) expression level correlates with clinical grading of bladder carcinomas

Hans Krause, Markus Muller, Steffen Weikert, Kurt Miller
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1216.
Published: 01 April 2004
View articletitled, The enhancer of zeste homolog 2 (EZH2) expression level correlates with clinical grading of bladder carcinomas
Journal Articles

Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids

Carsten Goessl, Hans Krause, Markus Müller, Rüdiger Heicappell, Mark Schrader, Jana Sachsinger, Kurt Miller
Journal: Cancer Research
Cancer Res (2000) 60 (21): 5941–5945.
Published: 01 November 2000
View articletitled, Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids
Open the PDF for Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids in another window
Journal Articles

Microsatellite Analysis of Plasma DNA from Patients with Clear Cell Renal Carcinoma

Carsten Goessl, Rüdiger Heicappell, Ralf Münker, Philippe Anker, Maurice Stroun, Hans Krause, Markus Müller, Kurt Miller
Journal: Cancer Research
Cancer Res (1998) 58 (20): 4728–4732.
Published: 01 October 1998
View articletitled, Microsatellite Analysis of Plasma DNA from Patients with Clear Cell Renal Carcinoma
Open the PDF for Microsatellite Analysis of Plasma DNA from Patients with Clear Cell Renal Carcinoma in another window
Journal Articles

Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection

Silvia Bulfone-Paus, Horst von Bernuth, René Rückert, Joachim Wachtlin, Daniela Ungureanu, Michael Notter, Hans Krause, Thomas Pohl, Ralf Paus, Ulrich Kunzendorf
Journal: Cancer Research
Cancer Res (1998) 58 (13): 2707–2710.
Published: 01 July 1998
View articletitled, Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection
Open the PDF for Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection in another window